Skip to main content
SpringerLink
Log in

Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5–7 cm) and very large (>7 cm) tumours

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

Evaluate the clinical outcome of CT-guided high-dose-rate-brachytherapy (CT-HDRBT) of hepatocellular carcinoma (HCC) larger than 5 cm in diameter with the goal of local tumour control (LTC).

Methods

Thirty-five patients with 35 unresectable HCCs ranging in size from 5 to 12 cm (mean: 7.1 cm) were treated with CT-HDRBT. Tumours were classified into two groups according to diameter: “large lesions” (5–7 cm) and “very large lesions” (>7 cm). Tumour response was evaluated by Gd-EOB-DTPA-enhanced liver magnetic resonance imaging (MRI) performed before, 6 weeks after, and then every 3 months after treatment. Endpoints included local tumour control (LTC), progression-free survival (PFS) and overall survival (OS).

Results

Nineteen tumours were classified as “large” and 16 as “very large”. Complete tumour enclosure was achieved in all patients after the first CT-HDRBT session. Five patients were lost to follow-up. At a mean follow-up of 12.8 months, two patients had local progression (6.7%), one in each group. Nine patients (30%) experienced distant progression, five (26.3%) in the “large” and four (25%) in the “very large” group. No patients died during the follow-up period. No major complications were recorded.

Conclusions

CT-HDRBT is a promising therapy for HCCs that exceed indications for thermal ablation.

Key Points

• Computed Tomography guided high-dose-rate brachytherapy offers new therapeutic options for hepatocellular carcinoma

• CT-HDRBT can be safely practised in HCCs exceeding 5 cm in diameter

• CT-HDRBT offers high rate of local control where thermal ablation is impossible

• CT-HDRBT could be a valid alternative to TACE for intermediate stage HCC

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bruix J, Llovet JM (2009) Major achievements in hepatocellular carcinoma. Lancet 373(9664):614–6

    Article  PubMed  Google Scholar 

  2. Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:762–73

    Article  PubMed  CAS  Google Scholar 

  3. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation. Cancer 88:2452–2463

    Article  PubMed  CAS  Google Scholar 

  4. Goldberg SN (2002) Comparison of techniques for image-guided ablation of focal liver tumors. Radiology 223:304–307

    Article  PubMed  Google Scholar 

  5. Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–7

    Article  PubMed  Google Scholar 

  6. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M et al (1993) Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 8:1121–1126

    Google Scholar 

  7. Gournay J, Tchuenbou J, Richou C, Masliah C, Lerat F, Dupas B et al (2002) Percutaneous ethanol injection vs resection in patients with small single hepatocellular carcinoma: a retrospective case–control study with cost analysis. Aliment Pharmacol Ther 16:1529–1538

    Article  PubMed  CAS  Google Scholar 

  8. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–8

    Article  PubMed  Google Scholar 

  9. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M et al (2004) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 58:1496–505

    Article  PubMed  Google Scholar 

  10. Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R et al (2010) Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 78:172–9

    Article  PubMed  Google Scholar 

  11. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M et al (2004) CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases. Strahlenther Onkol 180:274–80

    Article  PubMed  Google Scholar 

  12. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

    Article  PubMed  CAS  Google Scholar 

  13. Ricke J, Thormann M, Ludewig M, Jungnickel K, Grosser O, Wybranski C et al (2010) MR-guided liver tumor ablation employing open high-field 1.0 T MRI for image-guided brachytherapy. Eur Radiol 20:1985–93

    Article  PubMed  Google Scholar 

  14. Goldberg SN, Grassi CJ, Cardella JF, for the Society of Interventional Radiology et al (2009) Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377–90

    Article  PubMed  Google Scholar 

  15. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–9

    Article  PubMed  CAS  Google Scholar 

  16. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43

    Article  PubMed  Google Scholar 

  17. Ayav A, Germain A, Marchal F, Tierris I, Laurent V, Bazin C et al (2010) Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–9

    Article  PubMed  Google Scholar 

  18. Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, Chen Z et al (2011) Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in childs A Cirrhotics-a retrospective study of 1,061 Cases. J Gastrointest Surg 15:311–20

    Article  PubMed  Google Scholar 

  19. Yin XY, Xie XY, Lu MD, Xu HX, Xu ZF, Kuang M et al (2009) Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer 115:1914–23

    Article  PubMed  CAS  Google Scholar 

  20. Crocetti L, de Baere T, Lencioni R (2010) Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol 33:11–7

    Article  PubMed  Google Scholar 

  21. Yang WZ, Jiang N, Huang N, Huang JY, Zheng QB, Shen Q (2009) Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma. World J Gastroenterol 15:748–52

    Article  PubMed  Google Scholar 

  22. Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G (2006) Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16:661–9

    Article  PubMed  Google Scholar 

  23. Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312–27

    Article  PubMed  CAS  Google Scholar 

  24. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–90

    Article  PubMed  CAS  Google Scholar 

  25. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25–34

    Article  PubMed  CAS  Google Scholar 

  26. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–9

    Article  PubMed  Google Scholar 

  27. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–7

    Article  PubMed  CAS  Google Scholar 

  28. Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41–52

    Article  PubMed  Google Scholar 

  29. Riaz A, Kulik L, Lewandowski RJ, Ryu RK, Giakoumis Spear G, Mulcahy MF et al (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49:1185–1193

    Article  PubMed  Google Scholar 

  30. Kooby DA, Egnatashvili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J et al (2010) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21:224–230

    Article  PubMed  Google Scholar 

  31. Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S et al (2011) Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across barcelona clinic liver cancer stages: A European evaluation. Hepatology 26. doi:10.1002/hep.24451

  32. Grosso M, Vignali C, Quaretti P, Nicolini A, Melchiorre F, Gallarato G et al (2008) Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovasc Intervent Radiol 31:1141–9

    Article  PubMed  Google Scholar 

  33. Takeda A, Takahashi M, Kunieda E, Takeda T, Sanuki N, Koike Y et al (2008) Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity. Hepatol Res 38:60–69

    Article  PubMed  Google Scholar 

  34. Louis C (2010) Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results. Technol Cancer Res Treat 9(5):479–87

    PubMed  CAS  Google Scholar 

  35. Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW, Kim JH et al (2010) Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol 102:209–14

    Article  PubMed  Google Scholar 

  36. Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657–664

    Article  PubMed  Google Scholar 

  37. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma <4 cm. Gastroenterology 127:1714–1723

    Article  PubMed  Google Scholar 

  38. Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T et al (2010) Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:541–51

    Article  PubMed  Google Scholar 

  39. Wieners G, Pech M, Wust P, Miersch A, Streitparth F, Berg T et al (2005) CT-gestützte Brachytherapie bei hepatozellulärem Karzinom (HCC): Ergebnisse einer prospektiven Phase-II-Studie. Fortschr Röntgenstr doi:. doi:10.1055/s-2005-867648

  40. Mohnike K, Wieners G, Pech M, Seidensticker M, Rühl R, Lopez-Haenninen E et al (2009) Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma. Dig Dis 27:170–4

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic and Interventional Radiology, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany

    Federico Collettini, Dirk Schnapauff, Alexander Poellinger, Timm Denecke, Bernd Hamm & Bernhard Gebauer

  2. Department of Gastroenterology, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany

    Eckart Schott

  3. Department of Gastroenterology, Universitätsklinikum Leipzig, Liebigstrße 20, 04103, Leipzig, Germany

    Thomas Berg

  4. Department of Radiation Oncology, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany

    Peter Wust

Authors
  1. Federico Collettini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dirk Schnapauff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Poellinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Timm Denecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eckart Schott
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Thomas Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Peter Wust
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bernd Hamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bernhard Gebauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Collettini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collettini, F., Schnapauff, D., Poellinger, A. et al. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5–7 cm) and very large (>7 cm) tumours. Eur Radiol 22, 1101–1109 (2012). https://doi.org/10.1007/s00330-011-2352-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-011-2352-7

Keywords

Search

Navigation